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Abstract
Zbtb7c is a proto-oncoprotein that controls the cell cycle and glucose, glutamate, and lipid metabolism. Zbtb7c
expression is increased in the liver and white adipose tissues of aging or high-fat diet-fed mice. Knockout or
knockdown of Zbtb7c gene expression inhibits the adipocyte differentiation of 3T3-L1 cells and decreases adipose
tissue mass in aging mice. We found that Zbtb7c was a potent transcriptional repressor of SIRT1 and that SIRT1 was
derepressed in various tissues of Zbtb7c-KO mice. Mechanistically, Zbtb7c interacted with p53 and bound to the
proximal promoter p53RE1 and p53RE2 to repress the SIRT1 gene, in which p53RE2 was particularly critical. Zbtb7c
induced p53 to interact with the corepressor mSin3A-HADC1 complex at p53RE. By repressing the SIRT1 gene, Zbtb7c
increased the acetylation of Pgc-1α and Pparγ, which resulted in repression or activation of Pgc-1α or Pparγ target
genes involved in lipid metabolism. Our study provides a molecular target that can overexpress SIRT1 protein in the
liver, pancreas, and adipose tissues, which can be beneficial in the treatment of diabetes, obesity, longevity, etc.
Introduction
Sirtuins (SIRT1-7) are NAD+-dependent enzymes that
catalyze post-translational modifications of proteins. Sir-
tuins catalyze a range of deacetylation reactions, and some
family members, namely SIRT2, 4, and 6 require nicotine
adenine dinucleotide (NAD+) as a cofactor1. Together,
these SIRTs and NAD+ regulate critical cellular pathways
and are associated with aging and longevity. SIRT1 is the
best-characterized member of the mammalian sirtuin
family. SIRT1 deacetylases play roles in mitochondrial
biogenesis, glucose and lipid metabolism, DNA repair,
stress resistance, apoptosis, and inflammation2. Dysregu-
lation of SIRT1 expression or function has significant
implications in the development of obesity, diabetes,
cancer, cardiac disease, neurodegenerative disease, meta-
bolic dysregulation, etc.
Caloric restriction, fasting, and food withdrawal
increased SIRT1 expression in several rodents and human
tissues, such as white adipose tissue, liver, skeletal muscle,
brain, and kidney. The SIRT1 promoter contains two
Hypermethylated in Cancer1 (HIC-1) response elements
(HIC-1REs), an E2F1-binding element, and two p53-
binding elements (p53REs), insulin receptor substrate-1-
like binding sequences (IRS-1) and a FOXO1 forkhead-like
consensus binding site (FKHD-L). SIRT1 induction is
partially mediated by the interplay between cAMP
response element-binding protein (CREB) and carbohy-
drate response element-binding protein (ChREBP)3. CREB
and ChREBP independently bind to the SIRT1 promoter.
CREB activated by cAMP-dependent protein kinase (PKA)
activates SIRT1 transcription. In contrast, ChREBP is
rephosphorylated and translocated into the nucleus and
represses SIRT1 transcription3. FOXO1 binds to IRS-1 and
FKHD-L sites to activate rat SIRT1 transcrption4. Upon
acute nutrient withdrawal, FOXO3a interacts with p53,
© The Author(s) 2021
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Man-Wook Hur (mwhur2@yuhs.ac)
1Brain Korea FOUR Project for Medical Science, Department of Biochemistry &
Molecular Biology, Yonsei University School of Medicine, 50-1 Yonsei-Ro,
SeoDaeMoon-Ku, Seoul 03722, Korea
2Graduate School of Medical Science and Engineering, Korea Advanced
Institute of Science and Technology, DaeJeon 34141, Korea
Full list of author information is available at the end of the article


































and the complex binds to p53-binding sites to activate
SIRT1 transcription5. p53 can be a transcription activator
or repressor of the SIRT1 promoter, depending on the
presence of FOXO3a. It appears that p53 plays a critical
role in the transcriptional regulation of SIRT1 in response
to various signals.
Interestingly, SIRT1 expression is decreased by aging
and stress. An age-dependent decrease in SIRT1 expres-
sion in the liver is mediated by transcriptional repression
by the C/EBPβ-HDAC1 complex6. C/EBPα activates
SIRT1 transcription during adipogenesis by binding to the
C/EBP binding element7. SIRT1 protects cells from p53-
and FOXO3-mediated apoptosis in response to oxidative
stress8,9. NF-κB, which is a crucial stress response med-
iator, was shown to activate the SIRT1 promoter, and
SIRT1, in turn, inhibits NF-κB function by deacetylating
NF-κB10–12.
Interestingly, the POZ domain and Krüppel (POK)
family of transcription factors (HIC1, HIC2, and Zbtb7c)
regulate the expression of SIRT1. HIC1 (hypermethylated
in cancer 1) complexed with CtBP represses SIRT1 tran-
scription13. When DNA is damaged, HIC-1 and p53
jointly repress the SIRT1 gene by binding to two HIC-
1REs and two p53REs, respectively14. Recently, HIC2 was
shown to activate the transcription of SIRT115. Zbtb7c,
encoded by Zbtb7c, represses transcription by recruiting
cofactor complexes (e.g., HDAC, NuRD, and BCoR
complexes)16–19. Immunohistochemical analyses of Sirt1
expression in various tissues of Zbtb7c-KO mice showed
that Sirt1 is derepressed in all tissues tested (unpublished
data), suggesting that Zbtb7c may be a transcriptional
repressor of Sirt1.
Zbtb7c is a proto-oncoprotein that increases cell pro-
liferation by repressing the transcription of p21Cdkn1a by
inhibiting p53 or Miz-117,18. Zbtb7c increases Fasn tran-
scription20. Recently, we showed that Zbtb7c is vital in
gluconeogenesis during fasting and in glutamine meta-
bolism in cancer cells21,22. These results suggested that
Zbtb7c might be an essential regulator of metabolism.
Despite numerous publications on Sirtuin family pro-
teins, our understanding of these proteins and the mole-
cular mechanism by which dietary conditions and aging
regulate the SIRT1 gene is still limited, and more studies
are necessary. In this study, we found that Zbtb7c plays a
vital role in lipid metabolism by repressing SIRT1 tran-
scription through a unique mechanism that involves
molecular interaction between Zbtb7c and p53 and
switching the p53-interacting transcription coregulators
from p300 to mSin3A-HDAC1/3 at p53RE2.
Materials and methods
Mice
Animal experiments were approved by the Committee
on Animal Investigations of the Department of
Laboratory Animal Resources, Yonsei Biomedical
Research Institute, Yonsei University College of Medicine.
C57BL/6J mice were purchased from Charles River Japan
(Yokohama, Japan). The mice were housed in a specific
pathogen-free barrier facility under a 12-h light–dark
cycle. Food and water were provided ad libitum. At
12 weeks of age, mice were fed a high-fat diet (HFD, 60%
fat calories) for 14 weeks. The mice were euthanized by
cervical dislocation.
Plasmids, antibodies, and reagents
The pcDNA3.0-FLAG-Zbtb7c and pcDNA3.1-Zbtb7c
constructs were prepared by cloning full-length cDNA
into pcDNA3.0 or pcDNA3.1 (Invitrogen, CA). The
pGL2-SIRT1-Luc human SIRT1 promoter-luciferase
reporter gene fusion construct was generated by cloning
SIRT1 promoter DNA (−1250 ~ +79 bp) into pGL2-Basic
(Promega, WI). The pcDNA3-p53, pcDNA3-Sp1, and
corepressor expression vectors have been reported else-
where4,5. All plasmid constructs were verified by DNA
sequencing. Descriptions of the recombinant adenovirus
shRNA and siRNA against Zbtb7c mRNA have been
reported elsewhere18,21. Antibodies against p53, p300,
SIRT1, AMPK, phosphorylated APMK, PGC-1, PPARγ,
Zbtb7c, acetylated lysine, GAPDH, FLAG-Tag, Myc-Tag,
Ac-H3, Ac-H4, and mSin3A were purchased from
Upstate (Charlottesville, VA), Chemicon (Temecula, CA),
Cell Signaling Technology (Beverly, MA), Calbiochem
(San Diego, CA), and Santa Cruz Biotech (Santa Cruz,
CA). A rabbit polyclonal antibody against Zbtb7c was
prepared in-house using recombinant GST-POZ (a.a.
1–120) and purified using Affi-Gel 10 (Bio-Rad, CA).
Most of the chemical reagents were purchased from
Sigma (St. Louis, MO).
Cell cultures
Various cell types were cultured in the media recom-
mended by ATCC. Zbtb7c+/+ and Zbtb7c−/− mouse
embryonic fibroblasts (MEFs) were prepared through a
standard protocol and cultured in Dulbecco’s Modified
Eagle Medium (DMEM) (Gibco-BRL, MD) supplemented
with 10% fetal bovine serum (FBS) (Gibco-BRL, MD).
Serum lipid analysis
Cholesterol, triacylglycerol, and total lipids were mea-
sured by an enzymatic colorimetric or a colorimetric
method using an autoanalyzer (BS-400; MINDRAY,
China).
Transcription analysis of SIRT1 promoters
The promoter-reporter fusion construct pGL2-SIRT1-
Luc and the expression vectors pcDNA3-FLAG-Zbtb7c,
pcDNA3.1-Zbtb7c, pcDNA3-p53, pcDNA3.1-HIC-1, and
pCMV-LacZ, in various combinations were transiently
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transfected into cells using Lipofectamine Plus reagent
(Invitrogen, CA) and analyzed as described elsewhere15.
Reverse transcription and quantitative PCR (RT-qPCR) of
Zbtb7c, SIRT1, and SIRT1 target mRNA
Total RNA was isolated from the various cells using
TRIzol reagent (Invitrogen, CA). cDNA was synthesized
from 5 µg of total RNA, random hexamers (10 pmol), and
Superscript reverse transcriptase II (200 units) (Invitro-
gen, CA). RT-qPCR was performed using SYBR Green
Master Mix (Applied Biosystems, CA) in an Applied
Biosystems®7500 Real-Time PCR system. The oligonu-
cleotide primers used for the qPCR assays are listed in
Table 1.
Western blot analysis
Cells were harvested and lysed in RIPA buffer (50 mM
Tris-HCl, pH 8.0; 1% NP-40; 0.25% sodium deoxycholic
acid; 150 mM NaCl; 1 mM EGTA; and complete mini-
protease cocktail). Cell extracts (40 µg) were separated
using 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), transferred onto Immun-
BlotTM polyvinylidene difluoride (PVDF) membranes
(Bio-Rad, CA), and blocked with 5% skim milk (BD
Biosciences, MD). The blotted membranes were incu-
bated with antibodies against His-tag, Myc-tag (Cell Sig-
naling, MA), FLAG-tag (Sigma, MO), GAPDH
(Chemicon, CA), p53, HIC-1, Zbtb7c, mSin3A, and SIRT1
and then incubated with either an anti-mouse or anti-
rabbit secondary antibody conjugated to HRP (Vector
Laboratory, CA). Protein bands were visualized using an
ECL solution (PerkinElmer, CA).
For western blot analysis of mouse tissues, frozen tissue
samples were homogenized, and tissue lysates were
extracted by incubating cells in RIPA buffer (25 mM Tris-
HCl, pH 7.6; 150 mM NaCl; 1% NP-40; 1% sodium
deoxycholate; and 0.1% SDS) plus protease inhibitors
(Roche). Supernatants were collected following a brief
centrifugation, and protein concentrations in the super-
natants were measured using a BCA protein assay kit
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(Thermo Scientific, Rockford, IL, USA). The lysates were
then mixed with equal volumes of 2× Laemmli buffer (4%
SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.01% bro-
mophenol blue, and 120mM Tris-HCl, pH 6.8) and boiled
for 10min at 95 °C. Next, the protein samples were
separated by SDS–PAGE and transferred to a PVDF
membrane (Millipore). After blocking in a 5% skim milk
solution (Sigma), the membranes were incubated with the
following specific primary antibodies: anti-ZBTB7c anti-
body (diluted 1:1000, Biorbyt orb349355), anti-p53 anti-
body (diluted 1:1000, BD PharmingenTM 554157), and
anti-Actin antibody (diluted 1:1000, Cell Signaling #3700).
The membranes were then washed with 1 × TBST and
incubated with an anti-rabbit IgG horseradish peroxidase-
linked antibody or anti-mouse IgG antibody. The detec-
tion of each protein was performed using SuperSignal
West Pico Chemiluminescent Substrate (Thermo Scien-
tific) according to the manufacturer’s instructions. Signals
were captured by a ChemiDoc MP system (Bio-Rad). Blots
of tissue and cell lysates were quantified using
ImageJ (NIH).
Coimmunoprecipitation/western blot assays
Protein extracts from liver tissue were washed, pelleted,
and resuspended in lysis buffer supplemented with pro-
tease inhibitors (20 mm Tris-HCl, pH 7.5; 150mm NaCl;
10% glycerol; 1% Triton X-100; complete mini-protease
mixture (1 tablet/50 ml, Roche Applied Science)). Cell
lysates were precleared, and the supernatants were incu-
bated overnight with an anti-p53 antibody on a rotating
platform at 4 °C and then incubated with protein A/G
PLUS-Agarose beads (Santa Cruz, sc-2003). The beads
were collected, washed, and resuspended in equal
volumes of 5× SDS loading buffer. The immunoprecipi-
tated proteins were separated using 8 and 10% SDS-
PAGE. Western blot analysis was performed with the
appropriate antibodies as described above.
Chromatin immunoprecipitation and quantitative PCR
(ChIP-qPCR) assays
ChIP assays were performed to assess in vivo Zbtb7c
binding to distinct gene promoter regions. The primers
used are listed in Supplementary Table 1. NIH3T3 and
MEFs were transfected with increasing amounts of Zbtb7c
expression vector, pcDNA3.0-FLAG-Zbtb7c, or
pcDNA3.1-Zbtb7c. By ChIP assays, the molecular inter-
actions between Zbtb7c and p53 and histone modifica-
tions at the endogenous SIRT1 promoter were analyzed.
The levels of FLAG-tagged Zbtb7c binding at the p53REs
were analyzed using an anti-FLAG antibody (Sigma, Cell
Signaling). The levels of Zbtb7c and p53 protein binding
to the endogenous SIRT1 promoter were analyzed by
ChIP using polyclonal antibodies against Zbtb7c and p53
(Santa Cruz, CA). The following oligonucleotide primer
sets were designed to amplify the regions flanking the
p53-binding sites within the SIRT1 promoter and acety-




NIH3T3 cells, HCT116 p53+/+ cells, HCT116 p53−/−
cells, and MEFs were harvested and resuspended in lysis
buffer (20 mM Tris-HCl, pH 7.5; 150mM NaCl; 10%
glycerol; and 1% Triton X-100) supplemented with pro-
tease inhibitors. Cell lysates were precleared, supernatants
were incubated overnight with antibodies against Zbtb7c,
p53, Sp1, Myc, or p300 or a corepressor on a rotating
platform at 4 °C and then incubated with protein
A-Sepharose Fast Flow beads. The beads were collected,
washed, and resuspended in an SDS loading buffer. The
immunoprecipitated proteins were separated with
10–12% SDS-PAGE, and western blot assays were per-
formed as described above.
Oligonucleotide pull-down assays
NIH3T3 and HEK293 cells were lysed in HKMG buffer
(10 mM HEPES, pH 7.9; 100mM KCl; 5 mM MgCl2; 10%
glycerol; 1 mM DTT; and 0.5% NP40). Cell extracts were
incubated with 1 μg of biotinylated double-stranded oli-
gonucleotides (p53RE1 and p53RE2) for 16 hr. The oli-
gonucleotide sequences were as follows (only the top
strands are shown): p53RE1, 5′-AACAGCCTCCGCCCG
CCACGTGACCCGTAGTGTT-3′, and p53RE2, 5′-TGT
TGTGGTCTGGCCCGCGTGGGTGGCGGGAGCG-3′).
The core p53-binding sequences are underlined. The core
CGTG sequence was mutated in the pGL2-SIRT1-Luc
reporter mutant plasmids (Fig. 3b). The mixtures of cell
lysate and biotinylated oligonucleotide were incubated
with streptavidin-agarose beads for 2 h, washed with
HKMG buffer, and precipitated by centrifugation. The
precipitates were analyzed by western blotting using
antibodies against Zbtb7c, p53, and GAPDH, as
described above.
Statistical analysis
Student’s t test was used for statistical analyses.
Results
Zbtb7c regulates the transcription of SIRT1, Pparγ, and Pgc-
1α and various genes encoding lipid metabolism enzymes
Previously, we found that Zbtb7c regulates the expres-
sion of fatty acid synthase, a key enzyme of fatty acid
synthesis, suggesting that Zbtb7c plays a vital role in lipid
metabolism20. Interestingly, in the present study,
abdominal adipose tissue was significantly decreased in
aging Zbtb7c-KO mice (Fig. 1a, b). Histological sections of
gonadal WAT from the Zbtb7c-KO mice showed
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adipocytes that were smaller than those in the control
mice (Fig. 1c). We also found significant decreases in
triglycerides, total lipids, and serum cholesterol in the
blood of the Zbtb7c-KO mice (Fig. 1d).
Microarray analyses of differentially expressed genes in
the liver and WAT tissues of the Zbtb7c-KO mice showed
changes in the expression of genes important in lipid
metabolism (Fig. 1e and Supplementary Fig. 1). In Zbtb7c-
KO mice, the mRNA expression of two critical metabolic
regulators, Pparγ and Pgc-1α, and several other genes
involved in fatty acid metabolism (Ap2, Scd1, Cd36, and
Fans), adipocyte differentiation (Pparγ), and gluconeo-
genesis (G6pc and Pepck) were decreased. In contrast, the
expression of genes involved in fatty acid β-oxidation or
mitochondrial biogenesis (Cpt1a, Cyp4a10, Mcad, and
Pgc-1α) was increased. In particular, in both liver and
WAT tissues, the expression of Pparγ was downregulated,
and that of Pgc-1α was significantly upregulated.
Moreover, the expression of SIRT1, an essential regulator
of glucose production in the liver (via TORC2, PGC-1α,
and FOXO1), and lipid mobilization and metabolism in
adipose tissue (through PPARγ and LXR) were sig-
nificantly increased in Zbtb7c-KO mice (Supplementary
Fig. 1).
Using western blot assays, we also analyzed the
expression levels of signaling molecules upstream of Pgc-
1α and Pparγ, such as Ampk, phosphorylated Ampk, Akt,
and phosphorylated Akt in the liver and WAT. While the
total expression of Ampk remained unchanged, that of
phosphorylated Ampk, an activated form of Ampk that
stimulates β-oxidation and ketogenesis and inhibits fat
synthesis23, was significantly increased in the Zbtb7c-KO
mice (Supplemental Fig. 1b, d). The expression of Pgc-1α
was also upregulated, as expected. We also analyzed the
expression of Akt and phosphorylated Akt in WAT tis-
sues. Total Akt expression was similar in the WT and
Fig. 1 Zbtb7c-KO mice show reduced adipose tissue, and Zbtb7c inhibits fatty acid oxidation by regulating the expression of lipid
metabolism genes. a Body weight of WT and Zbtb7c-KO mice at 8 and 23 weeks. In aging Zbtb7c-KO mice, there was a significant decrease in body
weight. b Abdominal adipose tissue of 23-week-old WT and Zbtb7c KO mice. c Comparison of epididymal WAT from WT and Zbtb7c-KO mice.
d Blood serum levels of triglycerides, total lipids, and cholesterol in WT and Zbtb7c-KO mice—23 weeks after birth (n= 6). e Heat map of differential
mRNA expression of liver and adipose tissue in WT and Zbtb7c KO mice as determined by microarray analysis. f Extracellular flux (XF) analysis of
mitochondrial palmitate metabolism. The oxygen consumption rate (OCR) of Zbtb7c-KO mouse MEFs in the presence of exogenous palmitate was
increased, suggesting elevated β-oxidation of fatty acids by exogenous palmitate.
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knockout mice. Nevertheless, the expression of phos-
phorylated Akt, a multifunctional kinase that plays critical
roles in the inhibition of lipolysis and synthesis of fatty
acids23–25, was significantly decreased by Zbtb7c knock-
out. These results suggest that Zbtb7c plays an essential
role in lipid metabolism by regulating the expression and
activity of upstream signaling molecules such as Ampk
and Akt and the transcription of SIRT1 and Pparγ, Pgc-1α,
genes encoding lipid metabolism regulators in the liver
and WAT.
Because the expression of the genes involved in fatty
acid β-oxidation was increased in Zbtb7c-KO mice, we
investigated the oxygen consumption rates (OCRs) of
Zbtb7c WT and KO MEFs using a Seahorse XF24 Flux
Analyzer. Zbtb7c-KO MEFs treated with palmitate had a
higher baseline OCR. The Zbtb7c-KO MEFs showed an
increase in the palmitate-induced OCR, indicating higher
activity of fatty acid oxidation than induced in the WT
Zbtb7c MEFs (Fig. 1f).
Zbtb7c downregulates the transcription of SIRT1 and
stimulates adipocyte differentiation
The expression of Pgc-1α was upregulated and that of
Pparγ was downregulated in the Zbtb7c-KO mice. SIRT1
expression was derepressed in the liver and WAT of the
Zbtb7c-KO mice. These changes were likely to increase fatty
acid oxidation and reduce fat mass. Considering that the
Pgc-1α and Pparγ genes are downstream of SIRT1 and that a
negative correlation was found between SIRT1 and Zbtb7c
expression, we investigated whether Zbtb7c can repress
human SIRT1 transcription and thereby regulate Pgc-1α and
Pparγ expression or activity in three different mouse cell
types: MEFs, NIH3T3 cells, and differentiating NIH3T3-L1
cells. In MEFs with the Zbtb7c gene knocked out, SIRT1
expression was higher than that in WT MEFs (Fig. 2a, b).
While ectopic Zbtb7c repressed endogenous Sirt1 expres-
sion in NIH3T3 cells, knockdown of Zbtb7c expression by
infection with recombinant adenovirus expressing shZbtb7c
RNA increased endogenous Sirt1 expression (Fig. 2c, d). We
observed similar results in NIH3T3-L1 cells treated with
adipocyte differentiation inducers.
Because SIRT1 inhibits adipocyte differentiation, we
tested whether Zbtb7c can promote adipocyte differ-
entiation by repressing SIRT1 expression. Knockdown of
Zbtb7c expression derepressed or increased Sirt1 mRNA
expression by 3.7-fold and inhibited adipocyte differ-
entiation (Fig. 2e, f right). Knockdown of SIRT1 expres-
sion enhanced adipocyte differentiation (Fig. 2e).
Knockdown of both Zbtb7c and SIRT1 resulted in SIRT1
mRNA expression and adipocyte differentiation similar to
those of the control cells, suggesting that Zbtb7c represses
SIRT1 expression and thereby affects adipocyte differ-
entiation (Fig. 2e, f).
Zbtb7c represses SIRT1 transcription
Because SIRT1 and Zbtb7c expression showed a nega-
tive correlation, we investigated whether Zbtb7c can
repress the transcription of the human SIRT1 promoter.
By performing transient transfection and subsequent
transcription assays of four promoter and reporter gene
fusion constructs (pGL2-SIRT1-Luc) (−1.4, −0.9, −0.6,
and −0.3 kb sequences 5′-upstream from translation start
site) in HEK293 cells, we investigated whether HIC1, p53,
and Zbtb7c regulate SIRT1 transcription. HIC1 repressed
expression of the SIRT1 promoter by 50–60% (Fig. 3a
lanes 2, 6, 10, and 14). Zbtb7c also repressed reporter
expression by 55–65% (Fig. 3a lanes 4, 8, 12, and 16). p53
potently repressed the transcription of pGL2-SIRT1-Luc,
by more than 85% (Fig. 3a lanes 3 7, 11, and 15). We
noticed that transcriptional repression by Zbtb7c was
slightly more intense as the 5′-upstream sequence length
was shortened, and transcriptional repression by p53 was
somewhat weakened with the shortening of the sequen-
ces. Nonetheless, the data suggested that the proximal
promoter region (bp, −300 ~ +79) was sufficient for
transcriptional repression by p53 and/or Zbtb7c (Fig. 3a).
Interestingly, the short SIRT1 proximal promoter region
contains two p53REs (p53RE1 and p53RE2, which are
−188 ~ −181 bp and −159 to ~−152 bp from the ATG
translation start codon, respectively). We meticulously
investigated how the SIRT1 promoter was regulated by
HIC-1, p53, or Zbtb7c or by their combination. Zbtb7c
enhanced transcriptional repression of pGL2-SIRT1-Luc
WT through p53 (Fig. 3b lanes 3, 6), and this construct
was further repressed by HIC1 (Fig. 3b lanes 3, 6, 8).
To investigate the function of p53REs in transcriptional
regulation by the aforementioned factors (Zbtb7c, p53, and
HIC1), we introduced mutations at p53REs by site-directed
mutagenesis. The core CGTG sequences of either p53RE1
(−188 ~ −181 bp from the ATG translation start codon;
5′-ACGTGACC-3′) and/or p53RE2 (−159 ~ −152 bp in
the core sequence 5′-GCGTGGGT-3′) were replaced with
AGAG. Mutations in p53RE1 and/or p53RE2 profoundly
affected the transcriptional regulation of SIRT1 by p53,
Zbtb7c, and HIC1 (Fig. 3b). The mutation of p53RE1
abolished transcriptional repression that had been induced
by Zbtb7c, and interestingly, the mutation of p53RE2
resulted in potent transcriptional activation (2.5-fold) of
the SIRT1 promoter by Zbtb7c. The results suggested that
both p53RE1 and p53RE2 were involved in transcriptional
repression by p53 and Zbtb7c and suggested that p53RE2
was more critical in transcriptional repression by Zbtb7c.
In the mutant constructs, transcriptional repression
enhancement of the promoter by coexpressed p53 and
Zbtb7c was also lost and attenuated transcription repres-
sion that had been induced by p53 approximately one fold
(Fig. 3b, lanes 11 and 14 for the p53RE mutant 1 and lanes
19 and 22 for the p53RE mutant).
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Mutation of p53RE1 and/or p53RE2 in the SIRT1 pro-
moter resulted in weaker transcriptional repression by p53
than observed for the WT promoter. The mutation of
p53RE2 resulted in greater derepression. These data sug-
gested the importance and nature of p53 binding at p53RE1
and p53RE2. p53 binding to both p53RE1 and p53RE2 was
necessary and equally important in the transcriptional
repression by p53. These data also suggested that p53RE1
was critical in the transcriptional repression by Zbtb7c, and
mutation of the site abolished repression by Zbtb7c.
p53RE2 was also crucial in transcriptional repression by p53
and in intense transcriptional repression by molecular
interaction with Zbtb7c. Lack of p53 binding due to
mutation created a situation in which the SIRT1 promoter
was potently activated by Zbtb7c. In the mutant reporter
constructs, coexpression of p53 and Zbtb7c did not lead to
enhanced transcriptional repression as observed for the WT
promoter (Fig. 3b).
Fig. 2 Zbtb7c represses SIRT1 transcription and induces adipocyte differentiation. a, b qRT-PCR and western blot analyses of SIRT1 and Zbtb7c
expression in WT and Zbtb7c-KO MEFs. c, d qRT-PCR and western blot analyses of SIRT1 and Zbtb7c expression in NIH3T3 cells transfected with the
Zbtb7c expression vector. e Zbtb7c promoted adipocyte differentiation and/or lipid synthesis via SIRT1 repression. 3T3-L1 preadipocytes were
infected or transfected with recombinant Zbtb7c shRNA adenovirus and/or SIRT1 siRNA, cultured in differentiation medium for 14 days, and stained
with oil red O reagent. f qRT-PCR analysis of SIRT1 and Zbtb7c expression in 3T3-L1 cells treated as in (e).
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Fig. 3 Zbtb7c represses SIRT1 transcription by binding to p53REs. a Zbtb7c represses SIRT1 transcription. Transient transcription assays of the four
pGL2-SIRT1-Luc reporter construct in HEK293A cells. The Zbtb7c expression vector and reporter construct were transiently cotransfected, and luciferase activities
were measured. Averages of three independents assays are shown. Error bars, standard deviations. b Site-directed mutagenesis of p53RE1 and/or p53RE2 in
pGL2-SIRT1-Luc-1.3 kb. Transient transfection and transcription assays were performed to identify the critical elements in transcriptional repression of the SIRT1
promoter by Zbtb7c. p53RE2 was critical to transcriptional repression by Zbtb7c. c Oligonucleotide pull-down assays of Zbtb7c binding to the p53REs of the
SIRT1 promoter in NIH3T3 cells. The pulled-down proteins were then analyzed by western blotting using the antibodies indicated. Zbtb7c bound to p53REs
(equally well to both elements) and increased p53 binding to these elements. d qChIP assays of Zbtb7c, endogenous Hic-1, p53, and ectopic Zbtb7c binding to
the p53REs of the SIRT1 promoter in NIH3T3 cells. On p53RE regions, Zbtb7c binding was increased in a dose-dependent manner, but p53 binding remained
constant. The antibodies used were anti-FLAG (for FLAG-tagged Zbtb7c), anti-p53, anti-Hic-1, or control IgG antibodies. Error bars, standard deviations.
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Fig. 4 (See legend on next page.)
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Intrigued by these observations, we investigated the
molecular events (or DNA binding) among p53, Zbtb7c,
and p53REs to understand how SIRT1 gene transcrip-
tion is regulated. Oligonucleotide pull-down assays also
showed that ectopic Zbtb7c bound to both p53RE1 and
p53RE2 with similar binding affinity. p53 bound more
strongly to p53RE1 than to p53RE2, and ectopic Zbtb7c
showed slightly increased p53 binding (Fig. 3c). These
two different sets of data match closely, especially
considering the nature of ChIP assays. The two p53REs
are located very close to each other, and accordingly,
primer sets amplified the DNA regions encompassing
the p53RE1 and p53RE2 regions. p53RE1 appears to be
the primary site for p53 binding, and the p53–Zbtb7c
interaction seems to be important in Zbtb7c binding in
the region (Fig. 3c)
ChIP assays of NIH3T3 cells transfected with increasing
amounts of Zbtb7c expression vector showed a dose-
dependent increase in Zbtb7c binding to the elements
spanning the two p53REs, but p53 binding remained
virtually unchanged, although p53 binding after 9 µg of
Zbtb7c expression vector was transfected showed a weak
increase. HIC1 showed little binding activity (Fig. 3d). The
two different DNA-binding assays gave virtually identical
results.
Because p53 is a critical regulator of SIRT1 expression
in response to various stresses, Zbtb7c may repress
SIRT1 transcription by modulating molecular interac-
tions involving p53 at p53REs. We first tested whether
endogenous SIRT1 transcription repression by Zbtb7c is
affected by the presence or absence of p53. The knock-
down of Zbtb7c by shRNA resulted in strong derepres-
sion (an approximately 6-fold increase) of SIRT1 mRNA
in WT p53-expressing HCT116 cells. However, knock-
down of Zbtb7c in p53-null HCT116 cells resulted in
only weak derepression (1.4-fold) of SIRT1 mRNA,
suggesting that transcriptional repression by Zbtb7c
strongly requires p53 activity (Fig. 4a). Western blot
analyses of HCT116 cells showed similar results (Fig.
4b). These results indicated that Zbtb7c could potently
repress SIRT1 gene transcription in cells expressing p53
and weakly repress SIRT1 gene transcription in p53-null
cells. p53 appeared to play a pivotal role in the repression
of SIRT1 by Zbtb7c.
Zbtb7c interacts with p53, which increases p53 interaction
with corepressor mSin3A–HDAC complex, not coactivator
p300, decreasing the acetylation rate of histone H3 and H4
at the p53REs in the SIRT1 proximal promoter
Interestingly, Zbtb7c more potently repressed the SIRT1
gene promoter in cells expressing p53 than in cells not
expressing p53. p53 is a transcriptional repressor of the
SIRT1 gene promoter. We suspected that Zbtb7c might
have interacted with p53 and that this interaction led to
more potent transcriptional repression of SIRT1. Co-IP
and western blotting assays of the liver tissue extracted
from mice fed an HFD and the cellular extracts prepared
from cells transfected with the Myc-Zbtb7c and p53
expression vectors showed that the endogenous and/or
ectopically expressed Zbtb7c and p53 proteins interacted
with each other (Fig. 4c, top and bottom, and d).
We further investigated how Zbtb7c enhanced the
transcriptional repression of the SIRT1 promoter by p53.
p53 was previously shown to repress p21CDKN1A tran-
scription by interacting with the mSin3A-HDAC com-
plex18. Interestingly, our co-IP assays showed that ectopic
Zbtb7c increased the interaction between p53 and the
mSin3A-HDAC complex but decreased the p53 interac-
tion with p300 (Fig. 4d, left). the Co-IP assays of Zbtb7c-
KO MEF extract performed with anti-p53 antibody also
showed that the interaction of p53 with p300 was
increased, and the interaction with the mSin3A-HDAC
corepressor complex was weakened in the absence of
Zbtb7c expression (Fig. 4d right).
(see figure on previous page)
Fig. 4 Transcriptional repression of SIRT1 by Zbtb7c requires p53, and Zbtb7c increases binding of the mSin3A-HDAC1 complex to
p53REs. a, b Zbtb7c represses SIRT1 more strongly in WT p53 HCT116 cells than in p53-KO HCT116 cells. qRT-PCR and western blot analyses of
Zbtb7c and SIRT1 expression in WT TP53 and TP53-KO HCT116 cells. Cells infected with recombinant control adenovirus dl324 or recombinant dl324-
Zbtb7c-shRNA. GAPDH, control. c Top. p53 and Zbtb7c interacted with each other. Coimmunoprecipitation of p53 and Zbtb7c and western blot
assays. Liver extracts prepared from mice fed chow or HFD and NIH3T3 cell lysates with ectopic myc-Zbtb7c expression were subjected to
coimmunoprecipitation with anti-Zbtb7c or anti-p53 antibody and to western blotting for detection of the interaction with p53 or Zbtb7c,
respectively. Middle, histograms of the average protein band intensities of Zbtb7c, p53, and Gapdh. Western blot images were analyzed by ImageJ.
Bottom, co-IP and western blot analyses of molecular interactions between ectopically expressed Myc-tagged Zbtb7c and endogenous p53.
d Coimmunoprecipitation of p53, mSin3A, and p300 and western blot assays. Cell lysates were prepared from NIH3T3 cells transfected with
ectopically expressed Zbtb7c. In addition, total cellular extracts of WT and Zbtb7c-KO MEFs were prepared. The cell lysates were
coimmunoprecipitated with anti-p53 antibody and subjected to western blot assay for determination of the interaction with mSin3A and p300. The
precipitates were analyzed by western blotting with the antibodies indicated. GAPDH, control. e ChIP-qPCR assays were performed to assess
endogenous Zbtb7c, p53, mSin3a, and p300 binding to p53REs at the SIRT1 promoter in wild-type and Zbtb7c-KO MEFs. f ChIP-qPCR assays were
performed to assess endogenous Zbtb7c, p53, mSin3a, and p300 binding to p53REs at the SIRT1 promoter in NIH3T3 cells transfected with FLAG-
Zbtb7c. Error bars, standard deviations. In addition, the acetylation status of histone H3 and H4 near the proximal SIRT1 promoter is shown. IgG,
control ChIP antibody. Error bars, standard deviations.
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ChIP assays of the binding of various factors (Zbtb7c,
p53, mSin3A, and p300) in Zbtb7c-KO and WT MEFs
indicated that, in the absence of Zbtb7c, the binding of
mSin3A was decreased, and the binding of p300 was
significantly increased. The binding of p53 was not
affected (Fig. 4e). In addition, the ChIP assays of NIH3T3
cells transfected with the Zbtb7c expression vector
showed that while ectopic Zbtb7c expression did not
affect p53 binding, it increased mSin3A binding to p53RE
sites and decreased p300 binding (Fig. 4f). These mole-
cular changes induced by Zbtb7c decreased the acetyla-
tion of histones H3 and H4 around the p53REs of the
SIRT1 promoter, which decreased SIRT1 transcription
(Fig. 4e, f, right). Overall, these data suggested that Zbtb7c
interacted with p53, bound to p53RE sites, and increased
recruitment of the mSin3A-HDAC corepressor complex
to potently repress SIRT1 transcription.
Zbtb7c increases acetylation of the transcription factors
Pparγ and Pgc-1α by repressing SIRT1 expression and
decreasing the binding of Pparγ or Pgc-1α to target genes
Most reports support the idea that SIRT1 stimulates lipid
metabolism. For example, SIRT1 was previously shown to
regulate adipocyte differentiation and fatty acid oxidation by
deacetylating lysine residues in Pparγ and Pgc-1α26,27.
Because Zbtb7c repressed SIRT1 expression, we examined
whether Zbtb7c can increase the posttranslational acetyla-
tion of Pparγ or Pgc-1α. In NIH3T3 cells overexpressing
Zbtb7c, lysine acetylation of Pparγ and Pgc-1α was
increased, and lysine acetylation of Pparγ and Pgc-1α was
decreased in the Zbtb7c-KOMEFs (Fig. 5a, b). These results
indicated that Zbtb7c could have increased the acetylation
of Pparγ or Pgc-1α through the repression of SIRT1.
Furthermore, we tested whether Zbtb7c affected the
transcription of the pGL3-3x(PPRE)-TK-Luc reporter
plasmid carrying three Pparγ response elements in
NIH3T3 cells. Transient transfection and reporter
expression assays of the reporter plasmid (3xPPRE-Tk-
Luc) showed that Pparγ or Zbtb7c activated transcription
and that coexpression of Pparγ and Zbtb7c further
increased transcription (Fig. 5c). The ChIP assays of Pparγ
binding to the endogenous promoters of Pparγ target
genes, including aP2 and Cd36, showed an apparent
decrease in Zbtb7c KO MEFs by Pparγ deacetylation by
derepressed SIRT1. The ChIP assays also showed
decreased acetylation of histones H3 and H4 at the Pparγ
target gene promoters in Zbtb7c-KO MEFs, probably due
to decreased Pparγ binding. This outcome may explain
the low level of aP2 and Cd36 mRNA expression in
Zbtb7c-KO MEFs and mouse liver and WAT tissues (Fig.
6a, b and Supplementary Fig. 1).
We also tested whether Zbtb7c affected the transcription
of endogenous Pgc-1α target genes. Pgc-1α weakly repres-
sed transcription of the reporter construct pGL3-3x(PPRE)-
TK-Luc. Zbtb7c activated the reporter construct, probably
by increasing lysine acetylation of Pgc-1α, via SIRT1 gene
repression (Fig. 5c right). The ChIP assays showed increased
Pgc-1α binding at the endogenous promoters of its target
genes, such as Pdk4 and Mcad, in Zbtb7c-KO MEFs. The
ChIP/re-ChIP assays performed using Pgc1α and anti-
acetylated lysine antibodies showed decreased binding of
acetylated Pgc-1α in the Zbtb7c-KOMEFs. The ChIP assays
also showed increased acetylation of histones H3 and H4 in
the endogenous Pgc-1α target promoters Pdk4 and Mcad
because of increased Pgc-1α binding (Fig. 6c, d). These
results showed that Zbtb7c repressed the SIRT1 gene. In the
absence of Zbtb7c, lysine residues of Pgc-1α were deace-
tylated by derepression of SIRT1, which may explain the
inhibition of adipocyte differentiation and fatty acid synth-
esis and/or increased fatty acid oxidation. These data may
explain the apparent decrease in abdominal adipose tissue
in Zbtb7c-KO mice (Fig. 1b).
Zbtb7c expression is increased and SIRT1 expression is
decreased in mice fed an HFD and aging mice
Having revealed the molecular mechanism of SIRT1
transcription repression by Zbtb7c and p53, we investi-
gated the physiological significance of our findings. First,
we investigated the expression levels of Zbtb7c and SIRT1
in mice fed a normal chow diet and a HFD. Compared to
the normal chow-fed mouse controls, the Zbtb7c level
was increased by 2–8-fold and the SIRT1 mRNA level was
downregulated by 59–85% in the HFD-fed mice (Fig. 7a,
b. d). Additionally, at the protein level, Zbtb7c expression
was increased and SIRT1 expression was downregulated
in the eWAT and liver of the HFD-fed mice (Fig. 7c, e).
In addition, we investigated the expression patterns of
Zbtb7c and Sirt1 during aging. As mice age into adult-
hood and reach the late adult period, Zbtb7c mRNA
expression was increased up to 8–80-fold, and Sirt1 was
repressed by more than 80% in both WAT and liver tis-
sues. We observed similar changes in protein expression
(Fig. 7f–i). These data suggest that an HFD and aging can
cause increased Zbtb7c expression and thereby decreased
Sirt1 expression, which can affect diverse cellular pro-
cesses (e.g., lipid metabolism) controlled by Sirt1 target
genes, such as Pgc-1α, Foxo1, Foxo3, p53, Notch, Nf- κb,
Hif-1α, and Srebp-1c.
Discussion
SIRT1 has been studied for its role in caloric restriction,
prevention of aging-related disease, and maintenance of
metabolic homeostasis. Despite numerous publications on
SIRT1, our understanding of the molecular mechanism of
how the SIRT1 gene is regulated by diet conditions and
aging remains limited. Activation of SIRT1 by the activator
resveratrol or overexpression of SIRT1 can be beneficial for
the treatment of metabolic and neurodegenerative diseases
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such as type 2 diabetes, obesity, Alzheimer’s disease, and
Parkinson’s disease.
Previously, we and others showed that ZBTB protein
family members such as HIC1 and HIC2 regulated tran-
scription of the SIRT1 gene. HIC1 is a transcriptional
repressor that interacted with p53 and suppressed age-
dependent cancer development in mice. The loss of HIC1
function promoted tumorigenesis by derepressing SIRT1
and thereby attenuated p53 function by deacetylation,
which increases cancer risk in mammals14. Recently, we
found that HIC2, a homolog to HIC1 with differing
intermediate domains, is a transcriptional activator of
SIRT1 and may protect the heart from ischemia/reper-
fusion (I/R) injury15.
Interestingly, the tumor suppressor protein p53 was
previously shown to be a major regulator that activated or
repressed the SIRT1 gene depending on the physiological
conditions. SIRT1, upon DNA damage stress, repressed
transcription by binding to the two proximal p53-binding
elements14. In contrast, upon acute nutrient withdrawal,
p53 complexed with Foxo3a bound to the proximal p53-
binding sites and activated mouse Sirt1, in which both
p53RE1 and p53RE2 were equally important5. High
nucleotide sequence homology of the proximal promoter
regions (up to −220 bp regulatory region 5′-upstream
from the ATG translation initiation codon) of human and
mouse sirtuin genes suggested the functional importance
of p53 elements and molecular events involving p53 and
Fig. 5 Zbtb7c leads to the acetylation of Pparγ and Pgc-1α by repressing SIRT1. a Immunoprecipitation and western blot analyses of acetylated
Pparγ or Pgc-1α in WT and Zbtb7c-KO MEFs. b Immunoprecipitation and western blot analysis of acetylated Pparγ or Pgc-1α in NIH3T3 cells. The
lysates of NIH3T3 cells with ectopic FLAG-Zbtb7c expression were immunoprecipitated with anti-Pparγ or Pgc-1α antibody and analyzed by western
blotting with anti-FLAG, anti-Pgc-1α, anti-Pparγ, and anti-Gapdh antibodies. c Assays of transcriptional activity of Zbtb7c and Pparγ on pGL3-3x(PPRE)-
TK-Luc in HEK293A cells. The Zbtb7c expression plasmid, Pparγ expression plasmid, and pGL3-3x(PPRE)-TK-Luc were transiently cotransfected, the
cells were harvested after 48 h, and the luciferase reporter activity was measured. Error bars represent standard deviations. In addition, the
transcriptional activity of Zbtb7c and Pgc-1α on pGL3-3x(PPRE)-TK-Luc in HEK293A cells is shown. Luciferase reporter activity was measured as
described above.
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its interacting protein partners, such as Zbtb7c, in SIRT1
gene transcription. Further, 5′-upstream regions beyond
the −249 bp of the human SIRT1 and mouse Sirt1 genes
(from the ATG translation initiation codon) showed little
nucleotide sequence homology. Accordingly, the
molecular events revealed at the human SIRT1 proximal
promoter region (−248 bp from the ATG translation
codon) may be particularly applicable to the mouse Sirt1
gene, especially under starvation or HFD-fed conditions
and in aging mice (Fig. 8).
Fig. 6 Zbtb7c target gene expression and ChIP assays of Zbtb7c binding at target gene promoters. a, b ChIP assays of Pparγ binding to the
aP2 and Cd36 gene promoters. Lysates of WT and Zbtb7c-KO MEFs were immunoprecipitated with anti-Pparγ, anti-acetyl lysine, anti-AcH3, and Ac-H4
antibodies. IgG, control antibody. Error bars, standard deviations. c, d ChIP assay of Pgc-1α binding to the Pdk4 and Mcad gene promoters. Lysates of
WT and Zbtb7c-KO MEFs were immunoprecipitated with anti-Pgc-1α, anti-acetylated lysine, anti-AcH3, and Ac-H4 antibodies. IgG, control antibody.
Error bars, standard deviations.
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Fig. 7 A high-fat diet and aging increase Zbtb7c expression but decrease SIRT1. a RT-qPCR analysis of Zbtb7c mRNA expression in the livers
isolated from mice (n= 4) fed with chow or HFD. The mice fed with an HFD showed a lower level of Sirt1. b–e RT-qPCR analysis and western blot
analyses of Zbtb7c and Sirt1 mRNA and protein expression in the liver and white adipose tissues isolated from the mice fed chow or an HFD. An HFD
increased Zbtb7c expression but decreased Sirt1 expression. 18S RNA, RT-qPCR control; Gapdh, western control. On the right of (c) and (e), the
histographs of the western blot protein (Zbtb7c, Sirt1 normalized with Gapdh) band intensities as analyzed by ImageJ are shown. f–i RT-qPCR analysis
of Zbtb7c and Sirt1 mRNA expression in the eWAT and the liver isolated from mice (age 7, 14, 32, and 56 weeks). As the mice aged, Zbtb7c mRNA
expression was increased, while Sirt1 mRNA expression was decreased. On the right, the western blots and histogram of Zbtb7c and Sirt1 protein
expression are shown. 18S RNA, RT-qPCR control; β-actin, western control.
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Notably, although the two p53-responsive elements of
the mouse Sirt1 have been characterized to be functional
in regulating Sirt1 expression, the two mouse p53-
responsive elements (−178 and −168 bp responsive ele-
ments both identified through the Genomatrix software
package) did not show high sequence similarity to the
well-established p53 binding consensus sequence
(5′-WWWCGTGDDRRR-3′) of p53 target genes reg-
ulating cell cycle arrest and apoptosis in the previous
studies5,28.
In this study, considering the initial observations that (1)
abdominal adipose tissues were greatly reduced in old
Zbtb7c-KO mice, (2) deletion of the Zbtb7c gene led to
significant effects on lipid metabolism, and (3) the negative
correlation between SIRT1 and Zbtb7c expression, we
investigated and proposed a model of how SIRT1 gene
transcription might be regulated in mice fed an HFD and
in aging mice. Intriguingly, Zbtb7c induced by an HFD
and aging interacted with p53 and represses SIRT1
expression, in which p53RE2 (which is closer to the ATG
translation start codon) was more critical. Zbtb7c
increased the binding of the corepressor mSin3A–HDAC
complex to the p53–Zbtb7c complex at the p53REs, which
potently repressed SIRT1 gene transcription (Fig. 8).
Interestingly, in old Zbtb7c KO mice, abdominal adi-
pose tissue mass was significantly reduced. The SIRT1
promoter is thought to contain transcription regulatory
elements important in SIRT1 expression and thereby
adipocyte differentiation and adipogenesis. Zbtb7c mRNA
expression has been shown to be increased by con-
sumption of an HFD and aging. Aged Zbtb7c-KO mice in
our study showed a decrease in abdominal fat tissue.
Furthermore, microarray analyses of Zbtb7c-KO mouse
liver and white adipose tissues revealed significant chan-
ges in the expression of genes involved in lipid
metabolisms, such as aP2, Fans, Cd36, Fsp27, Cpt1,Mcad,
Pdk4, and SIRT1. Together, these findings suggested that
Zbtb7c is an important regulator of lipid metabolism.
Previous studies indicated that SIRT1 directly interacted
with and regulated the activity of two major transcription
factors and coregulators of lipid metabolism, Pparγ, and
Pgc-1α, via lysine deacetylation2,26 Because Zbtb7c
represses SIRT1, it may also affect the expression of target
genes such as Pparγ and Pgc-1α, as we demonstrated in
Zbtb7c-KO MEFs (Fig. 6). Because deacetylation inacti-
vates Pparγ but activates Pgc-1α, in our study, the target
genes of Pparγ were repressed, and the target genes of
Pgc-1α were upregulated by derepressed SIRT1 expres-
sion in the absence of Zbtb7c.
Zbtb7c, a potent transcriptional repressor of Sirt1 under
HFD feeding and aging conditions, may also affect various
physiological processes regulated by Sirt1, such as cell
survival, longevity, growth arrest, DNA repair, glucose
metabolism, adipogenesis, inflammatory responses, and
fatty acid oxidation. The results of our study suggested
broad roles and the importance of Zbtb7c as a regulator of
physiology. We were able to demonstrate that Zbtb7c is a
regulatory protein linking stress, such as that induced by
an HFD or aging, with SIRT1 expression. We were able to
identify a highly specific molecular target proximal pro-
moter element (p53RE2) that can be engineered to con-
trol the expression of SIRT1 in the liver, pancreas, skeletal
muscle, adipose tissues, etc., which can be beneficial in
glucose and lipid metabolism, metabolic syndrome, pan-
creatic beta-cell function and insulin secretion, type 2
diabetes, longevity, etc.
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